Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 -0.03 (-8.19%)
At close: Oct 1, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Vistagen Therapeutics' Depreciation & Amortization (CF) came in at $52,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 30.0% from $40,000 a year earlier and unchanged from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Vistagen Therapeutics reported Depreciation & Amortization (CF) of $211,000, up 35.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $199,000, up 32.7% from FY2025.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 11.1% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $150,000 in FY2025 (+18.1%), $127,000 in FY2024 (-2.3%) and $130,000 in FY2023.
  • The five-year range for quarterly Depreciation & Amortization (CF) is $30,600 (fiscal Q3 2023) to $54,000 (fiscal Q3 2026).
  • Year-over-year, Depreciation & Amortization (CF) has increased for nine consecutive quarters, with growth averaging 28.2% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q3 2022 (growth of 65.5%), and the weakest in fiscal Q3 2023 (a decline of 30.0%).
  • Business Quant data shows VTGN's Depreciation & Amortization (CF) at $52,000 (Q4 2026), $54,000 (Q3 2026) and $53,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - 52,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52,000.00
Mar 31, 2026 52,000.00
Dec 31, 2025 54,000.00
Sep 30, 2025 53,000.00
Jun 30, 2025 40,000.00
Mar 31, 2025 40,000.00
Dec 31, 2024 39,000.00
Sep 30, 2024 37,000.00
Jun 30, 2024 34,000.00
Mar 31, 2024 33,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 31,000.00
Jun 30, 2023 32,000.00
Mar 31, 2023 33,800.00
Dec 31, 2022 30,600.00
Sep 30, 2022 33,300.00
Jun 30, 2022 32,300.00
Dec 31, 2021 43,700.00
Sep 30, 2021 36,700.00
Jun 30, 2021 34,500.00
API Access

Vistagen Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=VTGN&period=max&api_key=YOUR_API_KEY